Latest news and research on all cancers and treatments, updated several times a week
And just last month, data from Roche's advanced bladder cancer study lit up the international medical community, pointing toward what could be the ...
NBI's potential visualization of bladder cancer symptoms has been acknowledged by the medical community, but in 2013 a meta-analysis reviewed ...
The results of another study found that frankincense oil may help with bladder cancer. The researchers concluded, "Frankincense oil might represent ...
Advaxis, Inc. (Nasdaq:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, ...
Mixed Results With Afinitor in Advanced Breast Cancer
Results in women with HER2-positive disease fall short, but a subset of patients see some survival benefit. Full story
Results in women with HER2-positive disease fall short, but a subset of patients see some survival benefit. Full story
Cancer News in Science Daily
“A breast cancer specialist and clinical researcher shows that adding either the chemotherapy drug carboplatin or the blood vessel-targeting drug bevacizumab to the standard treatment of chemotherapy before surgery helped women who have the basal-like subtype of triple-negative breast cancer.
“A family of RNA-binding proteins has been implicated in the regulation of cancer, particularly in a subtype of breast cancer, researchers report. These proteins, known as Musashi proteins, can force cells into a state associated with increased proliferation.
“By blocking a widespread enzyme, researchers have shown they can slow down the movement of cells and potentially stop tumors from spreading and growing.
“Traditional genomic, proteomic and other screening methods currently used to characterize drug mechanisms are time-consuming and require special equipment, but now researchers offer a multi-channel sensor method using gold nanoparticles that can accurately profile various anti-cancer drugs and their mechanisms in minutes.
“Using a computer algorithm that can sift through mounds of genetic data, researchers have identified several networks of genes that, when hit by a mutation, could play a role in the development of multiple types of cancer. The researchers hope the new genetic insights might aid in the development of new drugs and treatment approaches for cancer.
“Cervical cancer is, in many ways, a shining example of how successful the war on cancer can be. Thanks largely to the advent of Pap smear screening, U.S. cervical cancer deaths decreased dramatically, by more than 60 percent, between 1955 and 1992. In the last two decades, better treatment outcomes and more powerful imaging techniques have steadily pushed 5-year survival rates ever higher. The latest weapons in modern medicine's arsenal are two new vaccines that were recently approved by the U.S. Food and Drug Administration for preventing this type of cancer altogether.
“It's not unusual for people to use war metaphors such as "fight" and "battle" when trying to motivate patients with cancer. "Hearing metaphoric utterances is enough to change the way we think about a concept," said the study's lead investigator. "When we hear the phrase 'win the battle against cancer,' it forces us to think of cancer as if it's an enemy that we are at war with."
“New mechanisms of action of the novel anticancer agent FL118 have been reported by scientists, as well as new potential therapeutic targets for the agent, a camptothecin analogue.
“Neurology researchers have identified an important cell signaling mechanism that plays an important role in brain cancer and may provide a new therapeutic target. The researchers found that this mechanism -- a type of signaling termed constitutive or non-canonical epidermal growth factor receptor (EGFR) signaling -- is highly active in glioblastomas, the most common type of adult brain cancer and a devastating disease with a poor prognosis.
Tambahkan Komentar